Literature DB >> 11584326

Malignant granular cell tumor of soft tissues: a study of two new cases.

J Cruz-Mojarrieta1, S Navarro, E Goméz-Cabrera, L Peréz-Peña, P Soriano, A Peydró-Oyala, A Llombart-Bosch.   

Abstract

We describe 2 cases of malignant granular cell tumor. A marked discrepancy exists concerning the criteria of malignancy of this rare entity, which was diagnosed in male patients aged 41 and 52 years, respectively. They presented with tumors measuring more then 3.5 cm; one arose in the dermis and subcutaneous tissue in the region of the scapula, whereas the other was situated in deeper soft tissue in the pelvis. One case, with previous diagnosis of benign granular cell tumor, presented local recurrence 2 years after the initial diagnosis. The other case presented a fascicular pattern of growth invading adjacent muscular tissue. Both neoplasms were composed of polygonal and spindle cells, showing abundant cytoplasm, vesicular nuclei with large nucleoli, high nuclear-to-cytoplasmic ratio, and pleomorphism. Immunohistochemically, the neoplastic cells of both cases were positive for vimentin, S100 protein, neuron-specific enolase (NSE), and CD68. In addition, high expression of p53 and MiB1 (Ki67) was detected. Herein, we discuss the morphologic and immunohistochemical criteria of malignancy of granular cell tumors. Int J Surg Pathol 9(3):255-259, 2001

Entities:  

Mesh:

Year:  2001        PMID: 11584326     DOI: 10.1177/106689690100900315

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  2 in total

Review 1.  Solitary, multiple, benign, atypical, or malignant: the "Granular Cell Tumor" puzzle.

Authors:  Isidro Machado; Julia Cruz; Javier Lavernia; Antonio Llombart-Bosch
Journal:  Virchows Arch       Date:  2015-12-05       Impact factor: 4.064

2.  Atypical and malignant granular cell tumors in Japan: a Japanese Musculoskeletal Oncology Group (JMOG) study.

Authors:  Jungo Imanishi; Yasuo Yazawa; Tsuyoshi Saito; Michio Shimizu; Hiroyuki Kawashima; Keisuke Ae; Akihiko Matsumine; Tomoaki Torigoe; Hideshi Sugiura; Susumu Joyama
Journal:  Int J Clin Oncol       Date:  2016-01-13       Impact factor: 3.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.